Literature DB >> 8396816

Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product.

S Menzo1, M Clementi, E Alfani, P Bagnarelli, S Iacovacci, A Manzin, M Dandri, G Natoli, M Levrero, G Carloni.   

Abstract

The expression of the cellular gene coding for the epidermal growth factor (EGF) receptor (EGF-R) was assayed in the presence of hepatitis B virus (HBV) gene expression under different experimental conditions in human hepatoma-derived cells. First, transfection experiments of the well-differentiated HepG2 human hepatoma cell line using different expression vectors of the HBV X-region demonstrated that the X-gene product is capable of inducing EGF-R gene overexpression; in addition, by using a stable in vitro expression system for HBV, it was shown that EGF-R gene expression in these cells is greater than in the uninfected parent cells, and that this results in a three-fold increase in 125I-EGF binding. Finally, a CAT-expression assay was performed, indicating that regulatory regions of the EGF-R-gene are target sequences for X-protein trans-activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396816     DOI: 10.1006/viro.1993.1550

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  The hepatitis B virus X gene induces p53-mediated programmed cell death.

Authors:  P Chirillo; S Pagano; G Natoli; P L Puri; V L Burgio; C Balsano; M Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

3.  Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.

Authors:  Hailin Yang; Sung-Kwon Kim; Mikyung Kim; Pedro A Reche; Tiara J Morehead; Inger K Damon; Raymond M Welsh; Ellis L Reinherz
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.

Authors:  V Kumar; N Jayasuryan; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 5.  A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.

Authors:  Adam Yagui-Beltrán; David M Jablons
Journal:  Ann Thorac Cardiovasc Surg       Date:  2009-08       Impact factor: 1.520

6.  Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.

Authors:  Jie Liu; Angela Ahiekpor; Li Li; Xianxing Li; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

Review 7.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

8.  Hepatitis B virus infection associated with hematopoietic tumors.

Authors:  E Galun; Y Ilan; N Livni; M Ketzinel; O Nahor; G Pizov; A Nagler; A Eid; A Rivkind; M Laster
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

9.  A carboxy-terminal region of the hepatitis B virus X protein promotes DNA interaction of CREB and mimics the native protein for transactivation function.

Authors:  Honey Reddi; Ravinder Kumar; Swatantra Kumar Jain; Vijay Kumar
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

10.  The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.

Authors:  W E Miller; H S Earp; N Raab-Traub
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.